Kedudukan dalam Saham
#33046
Arctic Bioscience AS, a clinical-stage biotechnology company, engages in... Arctic Bioscience AS, a clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific. The company is developing HRO350, a novel oral drug which is in phase IIb for the treatment of mild-to-moderate psoriasis. It also sells nutraceuticals as intermediary and finished goods products under the ROMEGA brand name. Arctic Bioscience AS was incorporated in 2011 and is headquartered in Ørsta, Norway.
Perubahan (1 tahun)
-2.55%
Perdagangan Arctic Bioscience AS (ABS)
Harga ABS dengan permodalan pasaran b
Modal pasaran bagi Arctic Bioscience AS(ABS)
Modal Pasaran: $8.48M
Sehingga August 2026, Arctic Bioscience AS mempunyai modal pasaran sebanyak $8.48M. Ini menjadikan Arctic Bioscience AS syarikat ke-33046th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Arctic Bioscience AS dari 2021 hingga 2026
ABS berbanding dengan 5 teratas yang paling popular stocks
| Harga ABS |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.493T
|
+64,805,106.56%
|
|
|
|
|
$4.454T
|
+52,548,724.39%
|
|
|
|
|
$4.142T
|
+48,861,314.99%
|
|
|
|
|
$3.599T
|
+42,465,323.98%
|
|
|
|
|
$2.805T
|
+33,095,347.50%
|
